<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03105154</url>
  </required_header>
  <id_info>
    <org_study_id>15-402</org_study_id>
    <nct_id>NCT03105154</nct_id>
  </id_info>
  <brief_title>Groin Wound Infection Rate Using Prevena Compared to Standard Dressing in Vascular Surgery Patients With High Risk</brief_title>
  <acronym>PREVENA</acronym>
  <official_title>Experience With the Negative Pressure Incision Management System (Prevena) in Vascular Surgery Patients With High Risk for Groin Wound Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate wound healing using Prevena compared to standard dressings in high risk patients
      after vascular surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients submitted to bilateral femoral endarterectomy will have one groin dressed with
      PrevenaTM and the contralateral one dressed with conventional bandage immediately after
      suture. Both PrevenaTM and the conventional bandage at the contralateral side will be removed
      before the patient discharge. Groin wound complications such as deep space infection,
      cutaneous cellulitis, dehiscence or re-interventions for wound-related complications will be
      observed in a 30-day evaluation window. This observation will be performed during the patient
      admission and in the post-operative standard of care visits among the first 30 days.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patient will be randomized sequentially to Prevena alternating with standard of care dressing</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>% of infection at 30 days</measure>
    <time_frame>30 days</time_frame>
    <description>% of wound occurrence in the Prevena treated groin compared to conventional treated groin</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">26</enrollment>
  <condition>Endovascular Procedures</condition>
  <arm_group>
    <arm_group_label>Prevena Dressing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Groin dressed with Prevena</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Groin dressed with conventional bandage</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prevena Dressing</intervention_name>
    <description>Prevena dressing is applied on one groin</description>
    <arm_group_label>Prevena Dressing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional Dressing</intervention_name>
    <description>Conventional dressing is applied on the contralateral groin</description>
    <arm_group_label>Conventional Dressing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with known bilateral vascular peripheral disease who are being evaluated for
             possible bilateral femoral endarterectomy

          -  Patients with one or more risk factor (diabetes mellitus, Obesity, heavy smoker,
             immunodeficiency disease, groin reoperation, prosthetic)

          -  Patients in follow-up at Clinic in the Vascular Surgery Department

          -  Sign of informed consent

          -  English speaking

        Exclusion Criteria:

          -  Refusal to participate

          -  pregnancy

          -  unilateral femoral endarterectomy

          -  subjects for whom Prevena IMS is contraindicated
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leveser Kirksey</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leveser Kirksey, MD</last_name>
    <phone>216-444-2892</phone>
    <email>kirksel@ccf.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clevealnd Clnic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lee Kirksey, MD</last_name>
      <phone>216-444-2200</phone>
      <phone_ext>42892</phone_ext>
      <email>kirksel@ccf.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2017</study_first_submitted>
  <study_first_submitted_qc>April 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 7, 2017</study_first_posted>
  <last_update_submitted>February 5, 2018</last_update_submitted>
  <last_update_submitted_qc>February 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Levester Kirksey</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wound Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

